IGSF11 and cancer: Another example of a first-in-class inhibitor of the VISTA/VSIG-3 interaction is compound 7 [281,282] (Figure 7), as well as a VISTA degrader, which is a bifunctional molecule that demonstrates significant efficacy in inducing the immune system in the presence of cancer cells [281].